Catherine Guy

Duke Medical Center — United States

Medicine · Health Sciences

8h-index511citations20works0.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Diabetes Management and Research(11), Pancreatic function and diabetes(9), Diabetes and associated disorders(9), Hyperglycemia and glycemic control in critically ill and hospitalized patients(4), T-cell and B-cell Immunology(2)

Publications20 total

UEG Week 2023 Oral Presentations
United European Gastroenterology Journal·2023· 1 citedOpen Access
Molecular profiling of lung adenocarcinoma using a genomic laboratory hub approach: a single centre real-world experience
Lung Cancer·2023
Continuous glucose monitoring in extremely preterm infants in intensive care: the REACT RCT and pilot study of ‘closed-loop’ technology
Efficacy and Mechanism Evaluation·2021· 5 citedOpen Access
Real-time continuous glucose monitoring in preterm infants (REACT): an international, open-label, randomised controlled trial
The Lancet Child & Adolescent Health·2021· 71 citedOpen Access
Protocol of a randomised controlled trial of real-time continuous glucose monitoring in neonatal intensive care ‘REACT’
BMJ Open·2018· 14 citedOpen Access
Frequent Monitoring of C-Peptide Levels in Newly Diagnosed Type 1 Subjects Using Dried Blood Spots Collected at Home
The Journal of Clinical Endocrinology & Metabolism·2018· 19 citedOpen Access
Frequent Monitoring of C-peptide Levels in Newly Diagnosed Type 1 Subjects Using Dried Blood Spots Collected at Home
2018Open Access
Table of Contents 2
Diabetic Medicine·2017Open Access
β‐cell specific T‐lymphocyte response has a distinct inflammatory phenotype in children with Type 1 diabetes compared with adults
Diabetic Medicine·2016· 30 citedOpen Access
Evaluation of a Novel Method to Detect Residual sz-Cell Function by Dried Blood Spots in Children and Adolescents with a Recent Diagnosis of Type 1 Diabetes
55th ESPE Meeting·2016
Erratum. Blood and Islet Phenotypes Indicate Immunological Heterogeneity in Type 1 Diabetes. Diabetes 2014;63:3835–3845
Diabetes·2015Open Access
Real time continuous glucose monitoring in neonatal intensive care
http://isrctn.com/·2015
Effective recruitment of participants to a phase I study using the internet and publicity releases through charities and patient organisations: analysis of the adaptive study of IL-2 dose on regulatory T cells in type 1 diabetes (DILT1D)
Trials·2015· 13 citedOpen Access
Blood and Islet Phenotypes Indicate Immunological Heterogeneity in Type 1 Diabetes (vol 63, pg 3835, 2014)
2015· 1 cited
Blood and Islet Phenotypes Indicate Immunological Heterogeneity in Type 1 Diabetes
Diabetes·2014· 235 citedOpen Access
Multi-parametric flow cytometric and genetic investigation of the peripheral B cell compartment in human type 1 diabetes
Clinical & Experimental Immunology·2014· 56 citedOpen Access
Blood and Islet Phenotypes Indicate Immunological Heterogeneity in Type 1
2014
Postthymic Expansion in Human CD4 Naive T Cells Defined by Expression of Functional High-Affinity IL-2 Receptors
The Journal of Immunology·2013· 57 citedOpen Access
869 COFFEE CONSUMPTION INCREASES HEPATIC EXPRESSION OF CYTOCHROME P450S AND SIGNIFICANTLY REDUCES LIVER FIBROSIS IN PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE (NAFLD)
Journal of Hepatology·2011· 2 citedOpen Access
[Sucralfate and bezoars: data from the system of pharmacologic vigilance and review of the literature].
PubMed·1999· 7 cited

Frequent Co-authors

David B. Dunger(14), John A. Todd(11), Sefina Arif(7), Mark Peakman(7), Jake Powrie(6), Anna Lorenc(6), Pia Leete(4), Katherine Marks(4), Nurhanani Mohamed Nor(4), Megan Estorninho(4), Deborah Kronenberg‐Versteeg(4), Polly J. Bingley(4), Abby Willcox(4), Alan K. Foulis(4), Sarah J. Richardson(4), Emanuele de Rinaldis(4), Noel G. Morgan(4), Kathryn Beardsall(3), Lynn Thomson(3), Simon Bond(3)